Many anecdotal protocols pair them together, with BPC-157 for targeted healing and TB-500 for overall recovery support
Yes, not B12 related but recently treated a dog with a previously unopened antibiotic cream that was a couple of years out of date and it worked well
Note that coverage excludes iron deficiency anemia without documented underlying causes (e.g., chronic kidney disease, heart failure, chemotherapy-induced anemia)
In practice, a researcher selecting between them is usually choosing which mechanistic question to probe: vascular and cytoprotective signaling points toward BPC-157, while questions dominated by cell migration and cytoskeletal dynamics point toward TB-500
On the other side, the number of migrated cells decreased when the JNK1/2 and p38 MAPK signal pathways were blocked by their inhibitors SP600125 and SB203580, respectively, but no significant decline was noted